From March 10, 2021 to March 31, 2021, the company has repurchased 200,805 shares, representing 0.42% for KRW 623.82 million. With this, the company has completed the repurchase of 200,805 shares, representing 0.42% for KRW 623.82 million under the buyback announced on March 10, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,690 KRW | -2.54% |
|
-5.61% | -24.97% |
19/06 | IMBiologics Signs $964 Million Licensing Deal for Autoimmune Treatments | MT |
13/05 | MedInTech Inc. announced that it has received KRW 20 billion in funding from a group of investors | CI |
1st Jan change | Capi. | |
---|---|---|
-24.97% | 90.94M | |
+18.90% | 3.17B | |
+12.50% | 1.76B | |
+13.64% | 1.59B | |
-11.54% | 1.22B | |
+45.71% | 960M | |
+8.49% | 657M | |
+49.75% | 629M | |
-4.17% | 502M | |
+26.09% | 455M |
- Stock Market
- Equities
- A021080 Stock
- News Atinum Investment Co., Ltd
- Tranche Update on Atinum Investment Co., Ltd's Equity Buyback Plan announced on March 10, 2021.